Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Men's cancer screening knowledge targeted in new education trial

NCT ID NCT07087834

Knowledge-focused Sponsor: Pamukkale University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Sep 17, 2026 · Updated 3 times

Summary

This study tests whether a four-session education program called CASEM can improve men's perceptions, attitudes, and knowledge about cancer screening. Researchers will enroll 78 men in Turkey, split into an education group and a control group. The goal is to see if learning more leads to better screening habits.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Cancer Screenings Education for Men (CASEM) - a series of four weekly training sessions
What this could lead to
If successful, this education program could increase men's awareness and participation in cancer screening, potentially leading to earlier detection and better health outcomes.
What could go wrong
This is a small, early-stage study (78 men) measuring only knowledge and attitudes, not actual cancer rates. Results may not apply to other populations or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

78 people

The number who actually took part.

Started

Sep 2025

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

30 years and older

Sex

Male participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

In Turkey, the National Cancer Screening Program for men involves a fecal occult blood test every two years for those aged 50-70 and a colonoscopy every 10 years. Although men under the age of 50 are not included in the routine screening program, there are many simple screening methods for various cancers. After reviewing the literature and considering the current prevalence of cancer, it was decided that men aged 30 and older are suitable for sampling. The inclusion criteria for the study were determined in accordance with the relevant literature (Abasi et al., 2021; Echeverri et al., 2022; Makarov et al., 2021; Vernon et al., 2024). Inclusion criteria To be included in the study, participants must meet all of the following criteria: * Be 30 years of age or older at the time of the study, * Be at least literate, * Have no cognitive, visual, or orthopedic impairments that would prevent them from completing the questionnaires, * Be able to speak and understand Turkish, * Have no previous history of cancer diagnosis or cancer treatment, * Agree to participate in the study. Exclusion criteria Participants are excluded from the study if they meet any of the following criteria: * Having previously had cancer and undergone cancer treatment, * Not currently employed at the institution (e.g., on temporary assignment), * Refusing to participate in the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cancer screening are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cancer screening Men'S health screening

Contacts and locations

Locations

  • Pamukkale University

    Denizli, 20160, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.